Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Wnt5 signaling in vertebrate pancreas development

Hyon J Kim1,2 email, Jack R Schleiffarth3 email, Jose Jessurun4 email, Saulius Sumanas2 email, Anna Petryk1,3 email, Shuo Lin2 email and Stephen C Ekker1 email

Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455 USA

Department of Molecular, Cellular, and Developmental Biology, University of California, Los Angeles, Los Angeles, CA 90095 USA

Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455 USA

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455 USA

author email corresponding author email

BMC Biology 2005, 3:23doi:10.1186/1741-7007-3-23

Published: 24 October 2005

Abstract

Background

Signaling by the Wnt family of secreted glycoproteins through their receptors, the frizzled (Fz) family of seven-pass transmembrane proteins, is critical for numerous cell fate and tissue polarity decisions during development.

Results

We report a novel role of Wnt signaling in organogenesis using the formation of the islet during pancreatic development as a model tissue. We used the advantages of the zebrafish to visualize and document this process in living embryos and demonstrated that insulin-positive cells actively migrate to form an islet. We used morpholinos (MOs), sequence-specific translational inhibitors, and time-lapse imaging analysis to show that the Wnt-5 ligand and the Fz-2 receptor are required for proper insulin-cell migration in zebrafish. Histological analyses of islets in Wnt5a-/- mouse embryos showed that Wnt5a signaling is also critical for murine pancreatic insulin-cell migration.

Conclusion

Our results implicate a conserved role of a Wnt5/Fz2 signaling pathway in islet formation during pancreatic development. This study opens the door for further investigation into a role of Wnt signaling in vertebrate organ development and disease.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.